Date Title Description PDF
25 Apr 2023 On business and financial situation ROVI commences clinical development of a new three-monthly formulation of Letrozole (Letrozole LEBE) Download
21 Feb 2023 About Corporate Governance The Company informs about the agreements adopted by the Board of Directors Download
21 Feb 2023 On business and financial situation The Company releases the full year 2022 financial results presentation. Download
21 Feb 2023 On business and financial situation The Company releases the press release related to the full year 2022 financial results. Download
21 Feb 2023 On business and financial situation The company releases the Integrated Report for the year 2022 Download

Pages

Date Title Description PDF
26 Feb 2020 About corporate governance The Company informs about the agreements adopted by the Board of Directors Download
26 Feb 2020 Annual Corporate Governance Report ROVI releases the 2019 Annual Corporate Governance Report Download
26 Feb 2020 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2019 annual report regarding remuneration of the members of the Board of Directors  Download

Pages

Date Title Description PDF
08 May 2019 Information on P&L ROVI releases the first quarter 2019 results presentation Download
08 May 2019 Information on P&L ROVI releases the press release related to the first quarter 2019 financial results Download
07 May 2019 Liquidity contracts and specialists ROVI announces the signature of a new liquidity contract with Renta 4 Banco, S.A.     Download
30 Apr 2019 Liquidity contracts and specialists ROVI announces the termination of the liquidity contract signed with JB Capital Markets, S.V., S.A.U.     Download
11 Apr 2019 Strategic agreements with third parties The Company releases the press release related to the marketing agreement of Tetridar® in Spain   Download

Pages